Data taken at the time of data collection predate data archives and open access agreements, and participant consent has not been taken for data to be made widely available online (MRC-CFAS, University of Cambridge). Data are, however, available directly from the MRC-CFAS study whose authors may be contacted at CFAS Institute of Public Health Forvie Site University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus Cambridge CB2 0SR01223 330312 National coordinator: Linda Barnes <leb22@medschl.cam.ac.uk>.

Introduction {#sec005}
============

With an ageing population, the burden of stroke, already a significant cause of disability, is expected to rise. \[[@pone.0150178.ref001]\] It is relevant to identify predictors of stroke incidence and outcome to determine whether they might have any implications for stroke prevention and management.

Self-rated health (SRH) is a subjective assessment of overall health that has been shown to be an independent predictor of all-cause and disease-specific mortality, even after adjusting for objective biological measures and chronic disease. \[[@pone.0150178.ref002]--[@pone.0150178.ref004]\] It is speculated that the association of poor self-rated health with all-cause mortality may be driven by its association with cardiovascular diseases, in particular stroke.\[[@pone.0150178.ref005]\] SRH predicts incidence and death from cardiovascular diseases after adjusting for traditional cardiovascular risk factors and pre-existing disease. \[[@pone.0150178.ref006]\] However, few studies have reported the association of SRH with stroke incidence or mortality and those that do, have not always adjusted for important confounders such as disability, comorbidity and health behaviours. \[[@pone.0150178.ref007]--[@pone.0150178.ref009]\] It has been suggested that SRH may be particularly predictive of health outcomes in those with pre-existing conditions. \[[@pone.0150178.ref010]\] For example, Idler et al found SRH predicted all-cause mortality more strongly in those with pre-existing cardiovascular disease. \[[@pone.0150178.ref010]\] Similarly, Hillen et al found that a measure of comparative SRH at 3 months post-stroke predicted increased risk of recurrence in stroke survivors. \[[@pone.0150178.ref011]\] In individuals, stroke has been reported to contribute to greater losses in SRH status compared to other chronic conditions. \[[@pone.0150178.ref012]\] The relationship of SRH with mortality in stroke survivors is therefore of particular interest. Our aim was to determine whether SRH predicts stroke outcomes in older people with and without a prior history of stroke independent of disability levels, other comorbidities and health behaviours. The study used data from the first MRC Cognitive Function and Aging Study (MRC CFAS I), a study of older people aged 65 years and over recruited from the community. MRC CFAS I participants underwent physical, psychological, social and cognitive assessments at baseline, with follow-up including self-reported stroke after two years. Notifications of cause-specific mortality were received for up to 13 years.

Methods {#sec006}
=======

The MRC CFAS I is a multi-centre population-representative study of individuals aged 65 years and over (including those living in care homes). The study began in 1991 and was designed to estimate the prevalence and incidence of dementia as described elsewhere. \[[@pone.0150178.ref013]\]

The study has six centres across England and Wales chosen to represent the national variation of urban-rural mix, socio-economic deprivation and rates of chronic disease. \[[@pone.0150178.ref013]\] Five of these centres with identical study designs (Oxford, Nottingham, Cambridgeshire and Gwynedd) are used in the present investigation. The sixth centre (Liverpool) used a different design and is not included in the present study. Random samples of people in their 65th year and above were obtained from Family Health Service Authority lists (the agency responsible for maintaining registers of general practice populations at that time) from these five centres. The sample was stratified by age (65--74 years and 75 years and over) and equal numbers were randomly selected from these two age groups with the aim of recruiting 2500 to each centre.

Of those 16258 eligible and available to take part in CFAS, 13004 (80%) agreed to participate. All study centres obtained ethical approval from local research committees (Oxford Research Management & Governance, Nottingham Research Ethics Committee 1, Cambridge City Research Ethics Committee, East Cambs & Fenland Local Research Ethics Committee, North West Wales NHS Trust Research Governance Committee) and from the Eastern Multicentre Research Ethics Committee in the United Kingdom Ref: 05/MRE05/37. Eligible participants (or their proxies where appropriate) provided informed written consent.

Baseline Information {#sec007}
--------------------

Trained interviewers undertook baseline interviews in the participants' homes including assessments of socio-demographic characteristics, and disease history including previous stroke, coronary heart disease and diabetes (full details at [www.cfas.ac.uk](http://www.cfas.ac.uk/)).Socio-demographic factors collected included age, sex, marital status, type of accommodation and social class using the Registrar General's Occupational Classification with the detailed classification described elsewhere. \[[@pone.0150178.ref014]\]

The presence of stroke was determined from self-report through the question: "Have you ever had a stroke that required medical attention?"

General subjective health status or self-rated health (SRH) was determined with the question: "Would you say that for someone of your age, your own health in general is" followed by a list of four options: poor, fair, good or excellent.

Participants were asked about health behaviours including smoking status and alcohol intake. Comorbidities were assessed by asking: "Have you ever suffered from high blood pressure/angina/heart attack/diabetes/head-injury?" with each assessed in a separate question.

Functional status was determined by enquiring about activities of daily living (ADL) with ADL disability defined as requiring help at least several times per week with activities of daily living such as washing, cooking for him or herself, dressing, or if the respondent was housebound. Impairment of Instrumental activities of daily living (IADL) was determined as needing help with heavy housework or shopping and carrying heavy bags. Cognitive status was measured using the Mini Mental State Exam (MMSE). \[[@pone.0150178.ref015]\]

Follow-up {#sec008}
---------

At 2 years, re-screening interviews took place. At this time, the presence of non-fatal stroke was determined from self-report through the question: "Have you had a stroke in the last two years?"

All participants were flagged with the NHS Central Register. Information about date of death and stroke deaths was available in the CFAS until 31st December 2004.

Strokes recorded as either primary or underlying cause of death both (i) between baseline interview and the planned 2 year follow-up and (ii) at any time before December 2004, were defined using the ICD-9 codes 430--438 on death certification for each participant.

Analysis {#sec009}
--------

To determine whether SRH predicts stroke outcomes in older people, we asked two questions about those with and without a history of stroke:

1.  What is the association between baseline SRH, and stroke incidence and mortality at 2 years after baseline interview?

2.  What is the association between baseline SRH and stroke mortality and survival at 13 years follow-up?

All analyses were performed using Stata 11.1. Any participants who had missing data regarding presence of stroke or SRH or had an MMSE that was missing or less than 17 (as their responses could not be considered reliable for the purposes of this analysis), were excluded from the analyses at baseline.

The distribution at baseline of demographic, physical and social characteristics were described for participants with and without stroke. These included age group (65--74, 75--84, and 85+), sex, social class (divided into manual (IIIb, IV, V) and non-manual (I, II, IIIa)), and ADL (No impairment, impairment of IADL, impairment of ADL).

Two year incident stroke was defined by self or informant report at follow-up, or death from stroke (as primary or underlying cause) on the death certificate before the planned two year follow-up could take place.

Inverse probability weights were used throughout to ensure the sample was representative of the target population. Weights were estimated with logistic regression using presence in each phase of the study as an outcome and taking into account over-sampling of over-75s at baseline. Estimation of attrition weights for incident stroke included those who died during follow-up. Two year estimates of stroke incidence are therefore applicable to the whole of the population. The odds of having a stroke event or death from stroke were calculated at 2 years using logistic regression models. For these, SRH was dichotomised into two groups ('excellent/ good' or 'fair/poor').

Survival time until 2004 was calculated by subtracting the date of the screening baseline interview and date of death. If still alive, the time between the interview and the end of the follow-up period was used. The risk of death from all-causes and from stroke for both individuals with and without history of stroke were calculated using Cox Proportional Hazard models after testing the proportional hazard assumption (which was not violated) using the log-cumulative hazard plot and by comparing the predicted survival plot to the Kaplan-Meier plot. Death from other causes was treated as a censoring event.

Regression models and survival models were adjusted for baseline socio-demographic factors: sex, age group, marital status, social class; health-behaviour: smoking, alcohol drinking and co-morbidities: high blood pressure, angina, heart attack, diabetes, head injury and disability

Results {#sec010}
=======

Of those 16258 eligible and available to take part in CFAS, 13004 (80%) agreed to participate. 138 (1.1%) had information about stroke missing and were excluded from this analysis. 889 (6.9%) who had an MMSE missing or equal or below 17, (706 (5.9%) without stroke and 183 (19.0%) with stroke) were also excluded from the analysis. In addition, 20 participants (16 with stroke, 4 without stroke) who had missing data on SRH were excluded from analyses. In total 1,047 (8.0%) of participants were excluded from this analysis, leaving 11,957 eligible of which 11,181 (93.8%) had no stroke and 776 (6.2%) had one or more previous strokes.

At 2 years, 8,827 persons participated in the follow-up interview. By the end of 2004, 4878 participants (40.8%) included in the analysis were alive.

The baseline distribution of demographic, physical and social characteristics for participants with and without stroke have been previously fully reported. \[[@pone.0150178.ref016]\] Participants with stroke were older, more likely to be male, disabled, and have lower SRH ([Table 1](#pone.0150178.t001){ref-type="table"}). As reported previously, people with stroke were more likely to be of lower social class, former smokers, and to have comorbidities. \[[@pone.0150178.ref016]\]

10.1371/journal.pone.0150178.t001

###### Distribution of demographic variables in those with and without stroke in the population of England and Wales aged 65 years and older.

![](pone.0150178.t001){#pone.0150178.t001g}

                                              Individuals with stroke   Individuals without stroke            
  ------------------------------------------- ------------------------- ---------------------------- -------- ------
  **All**                                     776                       6.2                          11,181   93.8
  Sex                                                                                                         
  Females                                     400                       50.6                         6,674    59.0
  Males                                       376                       49.4                         4,507    41.0
  **Age**                                                                                                     
  Mean years                                  76.2                      6.6                          74.7     6.6
  **Self**-**rated Health**                                                                                   
  Excellent                                   59                        7.5                          2,349    21.3
  Good                                        280                       36.0                         5,535    49.7
  Fair                                        319                       40.9                         2,774    24.4
  Poor                                        118                       15.6                         523      4.7
  **Disabilities**                                                                                            
  None                                        333                       44.9                         8305     76.4
  IADL [†](#t001fn002){ref-type="table-fn"}   130                       16.4                         1557     13.2
  ADL [†](#t001fn002){ref-type="table-fn"}    311                       38.8.                        1292     10.4

\* Percentages backweighted to normal population

† IADL---impairments of instrumental activities of daily living ADL--impairments of activities of daily living

2.3% of those without a history of stroke included in the analysis, experienced a stroke event by two years compared to 14.3% of those who had a history of stroke, while 0.9% died from their stroke within this time in those without a history of stroke compared to 4.8% with a history of stroke. ([Table 2](#pone.0150178.t002){ref-type="table"}) By the end of 2004, 8.2% of those without a prior history of stroke and, 25.8% with a prior history of stroke experienced a fatal stroke.

10.1371/journal.pone.0150178.t002

###### Non-fatal and fatal stroke, survival and mortality at 2 years and follow-up until 30 December 2004 in those with or without stroke at baseline by self-rated health.

![](pone.0150178.t002){#pone.0150178.t002g}

  Baseline                           2 year Follow-up     Until 30 December 2004                                                                                                                    
  ---------------------------------- -------------------- ------------------------ --------------- --------------- -------------------- -------------------- -------------------- ----------------- ------
  **Total**                          **8,191 (67.6)**     **245 (2.0)**            **140 (1.1)**   **853 (6.8)**   **2,528 (22.6)**     **4878(40.8)**       **5887 (49.2)**      **1192 (10.0)**   
  ***No prior history of stroke***                                                                                                                                                                  
      All                            *7*,*757 (68*.*4)*   *168 (1*.*4)*            *103 (0*.*9)*   *767 (6*.*5)*   *2*,*386 (22*.*8)*   *4*,*746 (44*.*9)*   *5*,*447 (46*.*9)*   *988 (8*.*2)*     9.3
   **Self-rated health**                                                                                                                                                                            
   Excellent (n = 2349)              1,702 (71.7)         20 (0.7)                 21 (0.8)        97 (3.8)        509 (23.0)           1,264 (56.7)         905 (36.5)           180 (6.9)         10.0
   Good (n = 5535)                   3,997 (71.4)         85 (1.5)                 43 (0.7)        306 (5.2)       1,104 (21.3)         2,524 (48.2)         2,508 (43.5)         503 (8.3)         9.5
   Moderate (n = 2774)               1,771 (62.8)         57 (2.0)                 32 (1.1)        276 (9.5)       638 (24.7)           847 (33.0)           1,663 (58.0)         264 (9.0)         8.4
   Poor (n = 523)                    287 (53.8)           6 (1.2)                  7 (1.2))        88 (15.9)       135 (27.9)           111(22.7)            371(69.2)            41(8.1)           7.5
  ***Prior history of stroke***                                                                                                                                                                     
      All                            *434 (55*.*5)*       *77 (9*.*5)*             *37 (4*.*8)*    *86 (11*.*0)*   *142 (19*.*3)*       *132 (18*.*1)*       *440 (56*.*2)*       *204 (25*.*8)*    7.0
   **Self-rated health**                                                                                                                                                                            
   Excellent (n = 59)                38 (63.1)            5 (8.4)                  4 (7.0)         3 (4.7)         9 (16.8)             11 (17.9)            30 (55.1)            18 (26.9)         7.1
   Good (n = 280)                    115 (55.0)           34 (11.6)                9 (3.7)         26 (8.9)        56 (20.8)            60 (22.7)            147 (52.0)           73 (25.4)         7.4
   Moderate (n = 219)                183 (56.7)           26 (8.0)                 17 (4.9)        40 (12.8)       53 (17.6)            51 (17.4)            189 (57.8)           79 (24.8)         6.9
   Poor (n = 118)                    58 (50.0)            12 (9.2)                 7 (6.2)         17 (13.4)       24 (21.3)            10 (9.8)             74 (61.4)            34 (28.7)         6.1

\*Percentages backweighted to normal population

†Not interviewed at two years, but death data available

[Table 3](#pone.0150178.t003){ref-type="table"} shows that among those with no prior history of stroke, odds of stroke and all-cause mortality at 2 years were significantly higher in those with 'fair/poor' compared to 'excellent/good' SRH, after adjusting for potential confounding factors including socio-demographic factors, health-behaviours, co-morbidities and disability. The odds of death from stroke at 2 years were not significantly associated with SRH in people with no stroke history, although only 103 individuals in this group suffered a fatal stroke within two years.

10.1371/journal.pone.0150178.t003

###### Odds of stroke and all-cause mortality with poor SRH at 2 years in those with or without a prior history of stroke[\*](#t003fn001){ref-type="table-fn"} [^†^](#t003fn002){ref-type="table-fn"}

![](pone.0150178.t003){#pone.0150178.t003g}

                                   Odds of non-fatal stroke   Odds of fatal and non-fatal stroke   Odds of fatal stroke   Odds of all-cause mortality                                                              
  -------------------------------- -------------------------- ------------------------------------ ---------------------- ----------------------------- -------------------- ---------------- -------------------- -------------------
  **No prior history of stroke**   **1.7 (1.2--2.3)**         **1.5 (1.2--1.9)**                   **1.4 (1.0--1.8)**     **1.5 (1.1--1.9)**            **1.5 (1.0--2.3)**   1.2 (0.8--1.9)   **2.4 (2.0--2.7)**   **1.7(1.4--2.0)**
  **Prior history of stroke**      0.8 (0.5--1.3)             0.8 (0.4--1.3)                       0.9 (0.6--1.4)         0.9 (0.6--1.4)                1.4 (0.7--2.9)       1.1 (0.5--2.5)   **1.6 (1.1--2.4)**   1.1 (0.7--1.8)

\*Adjusted for socio-demographic factors: sex, age group, marital status, social class; health-behaviour: smoking, alcohol drinking and co-morbidities: high blood pressure, angina, heart attack, diabetes, head injury, disability

† Reference: 'excellent/good' versus 'fair/poor'

There was no significant association of SRH at baseline with stroke incidence, stroke death or of all-cause mortality at 2 years among those with a previous history of stroke.

In univariate analysis among those with no stroke history, there was an increased risk of stroke mortality among those with fair or poor SRH at 13 year follow up ([Table 4](#pone.0150178.t004){ref-type="table"}). This was largely attenuated in multivariate models with little evidence for an independent effect of SRH on stroke specific mortality. In those with a prior history of stroke there was no association of SRH with stroke specific mortality in the longer term.

10.1371/journal.pone.0150178.t004

###### Univariate and adjusted hazard ratios of 13 year survival from fatal stroke by self-rated health.[\*](#t004fn001){ref-type="table-fn"}
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  Self-rated health            Total participants at baseline   Alive or died because of other causes   Died with stroke as primary or underlying cause   HR (95% CI)Univariate   HR (95% CI) Adjusted for confounders
  ---------------------------- -------------------------------- --------------------------------------- ------------------------------------------------- ----------------------- --------------------------------------
  No prior history of stroke                                                                                                                                                      
  Excellent                    2349                             2169                                    180                                               1                       1
  Good                         5535                             5032                                    503                                               1.3(1.1--1.5)           1.2(1.0--1.4)
  Fair                         2774                             2510                                    264                                               1.7(1.4--2.0)           1.3(1.1--1.6)
  Poor                         523                              482                                     41                                                1.7(1.2--2.4)           1.2(0.9--1.7)
  Prior history of stroke                                                                                                                                                         
  Excellent                    59                               41                                      18                                                1                       1
  Good                         280                              207                                     73                                                0.8 (0.5--1.4)          0.8 (0.5--1.3)
  Fair                         319                              240                                     79                                                0.9(0.5--1.5)           0.8 (0.4--1.3)
  Poor                         118                              84                                      34                                                1.2(0.7--2.2)           1.1 (0.6--2.1)

\*Adjusted for socio-demographic factors: sex, age group, marital status, social class; health-behaviour: smoking, alcohol drinking and co-morbidities: high blood pressure, angina, heart attack, diabetes, head injury, disability

Discussion {#sec011}
==========

This study confirms that in the older population without a history of stroke, premorbid SRH independently predicts stroke incidence and all-cause mortality at 2 years. However, there was no evidence of a significant association between SRH and death from stroke at 2 years or fatal stroke after a 13 year follow-up period in this group. In the older population who had previously suffered a stroke, no significant relationship was found between SRH and stroke recurrence or death, or stroke survival.

Comparison with previous studies {#sec012}
--------------------------------

### SRH and stroke incidence--non-stroke population {#sec013}

Two previous studies have looked at the association of SRH with stroke incidence in unselected patient populations. Emmelin et al (2003) in an incident case-control study nested within the Vasternotten Intervention Programme and the Northern Sweden MONICA matched 473 cases with stroke with controls without known stroke history and found that after adjusting for diabetes and cardiovascular risk factors, SRH independently predicted the risk of stroke (death and non-fatal stroke combined) specifically for men with poor SRH who had a fourfold stroke risk compared with controls. \[[@pone.0150178.ref002]\] An analysis of 4770 mid-life adults participating in the US Health and Retirement study also found, after controlling for risk factors and health care utilisation, a significant association between SRH and first onset of stroke based on self-report (HR 1.54 p\< = .001), \[[@pone.0150178.ref017]\] of a strength similar to our own in older adults.

### SRH and stroke related mortality--non-stroke population {#sec014}

In the course of a systematic review and meta-analysis of studies reporting the relationship between SRH and cardiovascular disease outcomes (full description reported elsewhere), \[[@pone.0150178.ref006]\] we also identified three longitudinal studies that reported on fatal stroke outcome in unselected patient populations, which we used as a basis for a separate meta-analysis for this paper as well as a further study published after the systematic review. Details of the studies are found in [Table 5](#pone.0150178.t005){ref-type="table"}, and [Fig 1](#pone.0150178.g001){ref-type="fig"} summarises the results of the meta-analysis including our own study, for the non-stroke population. Tsuji et al (1994) and Fernández-Ruiz (2013) also studied older people. Tsuji et al had a follow-up period of 3 years, \[[@pone.0150178.ref007]\] Fang et al (2003) 8 years, \[[@pone.0150178.ref018]\] and Benjamins et al (2004) by far the largest study, 7 years, \[[@pone.0150178.ref019]\] while Fernández-Ruiz had a long follow-up similar to our study of 13 years. \[[@pone.0150178.ref005]\] While we analysed those with a prior history of stroke separately, Tsuji excluded those with baseline coronary heart disease and stroke from their study.

![Meta-analysis of fatal stroke events in unselected populations with varying degrees of control for CVD status and risk factors: 'poor' health relative to 'good/excellent' health](pone.0150178.g001){#pone.0150178.g001}

10.1371/journal.pone.0150178.t005

###### Characteristics of studies included in meta-analysis.
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  Study & **year published**   Country   Study Sample                                        Years follow up   SRH question (number of response options)   Population Baseline CVD status                      Baseline CVD risk factors & measurement   Analysis adjustments
  ---------------------------- --------- --------------------------------------------------- ----------------- ------------------------------------------- --------------------------------------------------- ----------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------
  Mavaddat (2014)              UK        N = 11,181 41% males Mean age 74.7                  13 (total)        \(4\) excellent vs poor                     Reported and those with stroke excluded             Demographics Risk Factors                 Age, sex, marital status, social class; health behaviours, ADL, co-morbidities
  Fernández-Ruiz (2013)        Spain     N = 4598 42.4% males Mean age 77.9                  13 (total)        \(5\) v. good vs v.poor                     Not reported                                        Demographics                              Age, sex, depression, MMSE, lifestyle, functional status
  Benjamins (2004)             USA       N = 689,710 46.2% males Mean age 44.4               7 (mean)          \(5\) v. good vs poor                       Not reported                                        Demographics, BMI                         Age, sex, race, education, marital status, family income, employment status
  Fang (2003)                  China     N = 3,157 48.7% males                               8 (total)         \(3\) excellent vs poor                     Reported Baseline CVD status but not risk factors   Demographics, BMI, BP                     Age, sex, marital status, residence, hospitalisation history during previous year, history of disease ADL, BMI, mental state and depression
  Tsuji (1994)                 Japan     N = 2,552 44.6% males Aged 65--113 at recruitment   2.9 (mean)        \(4\) excellent and good vs poor            Reported Baseline CHD and stroke excluded           Demographics, diabetes, hypertension      Age, sex, ADL disability, ambulatory activity, use of medical services

**Key:** SRH = self-rated health; BMI = body mass index; AMI = acute myocardial infarction; BP = blood pressure; SBP = systolic blood pressure; HDL = high density lipoprotein; LDL = low density lipoprotein; ADL = activities of daily living; MMSE = mini-mental state examination

Our meta-analysis suggests an overall significant relationship between SRH and stroke mortality (HR1.8 (1.3--2.5)). However, there was significant heterogeneity and a qualitative difference in results between studies.

Based on our findings and that of Fernández-Ruiz, it may be that any relationship of SRH with stroke mortality is not as strong in older as compared to younger people. However, our study also had better control of confounders including better measurement of self-report health behaviours, comorbidities and levels of physical disability than the studies involving younger participants. Compared to that of Fernández-Ruiz our study also controlled for comorbidities that serve as risk factors for stroke and we excluded all participants with a previous stroke from our analysis. Tsuji et al and Fernández-Ruiz also controlled for functional ability in their study and found no significant relationship between SRH and stroke mortality. There is a strong relationship between SRH and levels of physical disability, \[[@pone.0150178.ref003], [@pone.0150178.ref020]\] and it may be that in older people, any relationship between SRH and stroke mortality found in other studies may have been mediated by disability level, itself a risk factor for stroke. \[[@pone.0150178.ref021]\]

### SRH and stroke-related mortality--people with previous stroke {#sec015}

Hillen et al (2003) is the only study to investigate the association of SRH with stroke recurrence in people with previous stroke. \[[@pone.0150178.ref011]\] They found, like us, that current SRH status did not relate to recurrence-free survival, but also that SRH transition was associated with stroke recurrence in those with change to worse SRH status. It has been hypothesised that SRH may be more predictive of mortality in those with pre-existing conditions, partly because the presence of a diagnosis may influence self-ratings. Idler et al. found that SRH predicts subsequent mortality more strongly in those with circulatory system disease than in those with no identified cardiovascular condition. \[[@pone.0150178.ref010]\] In our previous meta-analysis (which included Idler et al), we did find a significant association of SRH with CVD mortality in people with existing CVD, but these studies had not adjusted for disability levels and were in younger populations. \[[@pone.0150178.ref006]\] A possible explanation for our different finding in stroke survivors is that although those with more severe cognitive deficits were excluded in our study, it is possible that some were less able to adequately respond to the SRH question or used different measures by which to assess their health compared to those without physical or cognitive disabilities. Alternatively, it is plausible that the presence of stroke overwhelms the predictive effects of SRH on further stroke events and death.

Study limitations {#sec016}
-----------------

Non-fatal stroke data in CFAS were dependent on self or proxy report, and some older people may have omitted reporting a milder stroke or reported a stroke in the absence of a confirmed diagnosis, thus potentially under or overestimating any relationship between SRH and stroke outcome. Baseline and two-year follow-up were carried out in the 1990s and changes in rates of vascular events or survival from vascular events may have occurred since then. Detailed cardiovascular risk factors were not available in this study and not all comorbidities were adjusted for. For example the presence or absence of atrial fibrillation was not recorded.

Conclusion {#sec017}
==========

This study confirms that in the older population without a history of stroke, SRH predicts overall mortality. Consistent with this there is a small but significant independent relationship between poor SRH and stroke incidence. However there is no relationship between SRH and stroke mortality in the short or longer term in the older population. In older people with a history of stroke, there is no relationship between SRH and stroke outcomes.

While in older stroke survivors, SRH does not predict future stroke events, it may nevertheless have other prognostic value. The relationship of SRH with health outcomes such as institutionalisation and functioning in stroke survivors warrants further study. For the older population without a history of previous stroke, SRH may be helpful in predicting who may be at risk of developing a stroke in the near future. Self-rated health is a multidimensional construct, an "effective summary" of multiple measures and dimensions of health incorporating not only the presence of disease and symptoms but a wide range of lifestyle and psychosocial predictors. \[[@pone.0150178.ref020], [@pone.0150178.ref022]--[@pone.0150178.ref024]\] We have previously reported on determinants of self-rated health in older individuals with or without a stroke in the MRC CFAS 1 where a number of modifiable factors such as 'presence of depression' and 'getting out and about' were identified. \[[@pone.0150178.ref016]\] Increased attention to screening and addressing these and other reasons for poor SRH in the older population may therefore be warranted.
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